ATAI Life Net Worth
ATAI Life Net Worth Breakdown | ATAI |
ATAI Life Net Worth Analysis
ATAI Life's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ATAI Life's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ATAI Life's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ATAI Life's net worth analysis. One common approach is to calculate ATAI Life's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ATAI Life's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ATAI Life's net worth. This approach calculates the present value of ATAI Life's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ATAI Life's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ATAI Life's net worth. This involves comparing ATAI Life's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ATAI Life's net worth relative to its peers.
Enterprise Value |
|
To determine if ATAI Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ATAI Life's net worth research are outlined below:
| ATAI Life Sciences is way too risky over 90 days horizon | |
| ATAI Life Sciences may become a speculative penny stock | |
| ATAI Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 314 K. Net Loss for the year was (40.22 M) with profit before overhead, payroll, taxes, and interest of 233 K. | |
| ATAI Life Sciences currently holds about 304.06 M in cash with (84.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| ATAI Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Atai Life Sciences stock target cut, retains buy rating on developments |
ATAI Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ATAI Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ATAI Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know ATAI Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ATAI Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATAI Life Sciences backward and forwards among themselves. ATAI Life's institutional investor refers to the entity that pools money to purchase ATAI Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Advisorshares Investments, Llc | 2024-09-30 | 167.8 K | Bank Of America Corp | 2024-06-30 | 125.5 K | Geode Capital Management, Llc | 2024-09-30 | 92.6 K | State Street Corp | 2024-06-30 | 81.1 K | Sg Americas Securities, Llc | 2024-09-30 | 50.3 K | Royal Bank Of Canada | 2024-06-30 | 49.7 K | Sanctuary Advisors, Llc | 2024-06-30 | 48.7 K | Hpm Partners Llc | 2024-06-30 | 48 K | Virtu Financial Llc | 2024-06-30 | 47 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 5.4 M | Walleye Trading Advisors, Llc | 2024-06-30 | 2.8 M |
Follow ATAI Life's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 281.91 M.Market Cap |
|
Project ATAI Life's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.14) | |
| Return On Capital Employed | (0.46) | (0.48) | |
| Return On Assets | (0.14) | (0.14) | |
| Return On Equity | (0.17) | (0.17) |
When accessing ATAI Life's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ATAI Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ATAI Life's profitability and make more informed investment decisions.
Evaluate ATAI Life's management efficiency
ATAI Life Sciences has return on total asset (ROA) of (0.2541) % which means that it has lost $0.2541 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6277) %, meaning that it created substantial loss on money invested by shareholders. ATAI Life's management efficiency ratios could be used to measure how well ATAI Life manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.14. The current Return On Capital Employed is estimated to decrease to -0.48. As of now, ATAI Life's Total Current Assets are increasing as compared to previous years. The ATAI Life's current Debt To Assets is estimated to increase to 0.06, while Total Assets are projected to decrease to under 261.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.54 | 1.46 | |
| Tangible Book Value Per Share | 1.54 | 1.46 | |
| Enterprise Value Over EBITDA | (5.45) | (5.73) | |
| Price Book Value Ratio | 0.92 | 0.97 | |
| Enterprise Value Multiple | (5.45) | (5.73) | |
| Price Fair Value | 0.92 | 0.97 | |
| Enterprise Value | 198.1 M | 207.9 M |
Evaluating the management effectiveness of ATAI Life allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The ATAI Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 664.0333 | Revenue 331 K | Quarterly Revenue Growth (0.54) | Revenue Per Share 0.002 | Return On Equity (0.63) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ATAI Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on ATAI Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ATAI Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ATAI Life time-series forecasting models is one of many ATAI Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ATAI Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
ATAI Life Earnings per Share Projection vs Actual
ATAI Life Corporate Management
| Ryan JD | General VP | Profile | |
| Ryan Barrett | General VP | Profile | |
| Rolando MD | Chief Officer | Profile | |
| Stephen Bardin | Advisor | Profile | |
| Michael Raven | Senior Operations | Profile | |
| Madison Crawford | Sr Accounting | Profile | |
| Glenn Short | Senior Development | Profile |
Already Invested in ATAI Life Sciences?
The danger of trading ATAI Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ATAI Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ATAI Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ATAI Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (0.80) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.54) | Return On Assets (0.25) |
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.